Thomas E. Denion

Array ( [id] => 7126905 [patent_doc_number] => 20050058649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Antibodies directed to phospholipase A2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/726332 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30219 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058649.pdf [firstpage_image] =>[orig_patent_app_number] => 10726332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297215 [patent_doc_number] => 20040214768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and materials for treating inflammatory conditions' [patent_app_type] => new [patent_app_number] => 10/724662 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11573 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214768.pdf [firstpage_image] =>[orig_patent_app_number] => 10724662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116243 [patent_doc_number] => 20050069544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Pharmaceutical composition and a method of treatment' [patent_app_type] => utility [patent_app_number] => 10/701682 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13504 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069544.pdf [firstpage_image] =>[orig_patent_app_number] => 10701682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7676943 [patent_doc_number] => 20040152883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Tocopherol associated protein and uses thereof' [patent_app_type] => new [patent_app_number] => 10/696699 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9325 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152883.pdf [firstpage_image] =>[orig_patent_app_number] => 10696699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379848 [patent_doc_number] => 20040081619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Method of prophylaxis against large myocardial infarctions' [patent_app_type] => new [patent_app_number] => 10/690190 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3833 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081619.pdf [firstpage_image] =>[orig_patent_app_number] => 10690190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630982 [patent_doc_number] => 20060147450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists' [patent_app_type] => utility [patent_app_number] => 10/529835 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21443 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147450.pdf [firstpage_image] =>[orig_patent_app_number] => 10529835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655196 [patent_doc_number] => 20060140931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment' [patent_app_type] => utility [patent_app_number] => 10/527937 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22225 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140931.pdf [firstpage_image] =>[orig_patent_app_number] => 10527937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7237561 [patent_doc_number] => 20050080010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Suppression of immune response via inhibition of cathepsin S' [patent_app_type] => utility [patent_app_number] => 10/641872 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12475 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080010.pdf [firstpage_image] =>[orig_patent_app_number] => 10641872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196457 [patent_doc_number] => 07638323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Fusion proteins and methods of producing same' [patent_app_type] => utility [patent_app_number] => 10/638820 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23798 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638323.pdf [firstpage_image] =>[orig_patent_app_number] => 10638820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202738 [patent_doc_number] => 20040086952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => '5-Lipoxygenase-activating protein II' [patent_app_type] => new [patent_app_number] => 10/627807 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10158 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086952.pdf [firstpage_image] =>[orig_patent_app_number] => 10627807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307409 [patent_doc_number] => 20040141967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Methods and compositions for treating macrophage-mediated diseases' [patent_app_type] => new [patent_app_number] => 10/627307 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141967.pdf [firstpage_image] =>[orig_patent_app_number] => 10627307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467544 [patent_doc_number] => 20040053831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Veterinary immunisation vectors' [patent_app_type] => new [patent_app_number] => 10/398916 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9033 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053831.pdf [firstpage_image] =>[orig_patent_app_number] => 10398916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 493080 [patent_doc_number] => 07211408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Recombitope peptides' [patent_app_type] => utility [patent_app_number] => 10/463113 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 15717 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211408.pdf [firstpage_image] =>[orig_patent_app_number] => 10463113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216691 [patent_doc_number] => 20040071726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Peptide epitopes recognized by antigen specific cd4lymphocytes' [patent_app_type] => new [patent_app_number] => 10/380136 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20350 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071726.pdf [firstpage_image] =>[orig_patent_app_number] => 10380136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166687 [patent_doc_number] => 20040077045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'MAGE peptides presented by HLA class II molecules' [patent_app_type] => new [patent_app_number] => 10/444683 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28288 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077045.pdf [firstpage_image] =>[orig_patent_app_number] => 10444683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769979 [patent_doc_number] => 20030215919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Phosphodiesterase 8A' [patent_app_type] => new [patent_app_number] => 10/440998 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12295 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215919.pdf [firstpage_image] =>[orig_patent_app_number] => 10440998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510753 [patent_doc_number] => 07199225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Human extracellular matrix-1' [patent_app_type] => utility [patent_app_number] => 10/435392 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12669 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199225.pdf [firstpage_image] =>[orig_patent_app_number] => 10435392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402876 [patent_doc_number] => 20040019187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Immunomodulatory human mhc class II antigens-binding polypeptides' [patent_app_type] => new [patent_app_number] => 10/275046 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 26468 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019187.pdf [firstpage_image] =>[orig_patent_app_number] => 10275046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6808697 [patent_doc_number] => 20030198636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Process for inhibiting complement activation via the alternative pathway' [patent_app_type] => new [patent_app_number] => 10/419565 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16421 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198636.pdf [firstpage_image] =>[orig_patent_app_number] => 10419565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724997 [patent_doc_number] => 20030207309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Diagnostics and therapeutics for macular degeneration-related disorders' [patent_app_type] => new [patent_app_number] => 10/419305 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26522 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207309.pdf [firstpage_image] =>[orig_patent_app_number] => 10419305 [rel_patent_id] =>[rel_patent_doc_number] =>)